Strategy Asset Managers LLC Pfizer Inc Transaction History

Strategy Asset Managers LLC

$518 Million
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$25.26 - $29.6 $5.31 Million - $6.23 Million	210,341 Added 2179.93%	219,990 $6.16 Million
Q1 2024 Apr 25, 2024	BUY	$25.89 - $29.73 $3,961 - $4,548	153 Added 1.61%	9,649 $267,000
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $4.76 Million - $6.18 Million	-182,228 Reduced 95.05%	9,496 $273,000
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $907,055 - $1.06 Million	-28,266 Reduced 12.85%	191,724 $6.36 Million
Q2 2023 Aug 24, 2023	BUY	$36.12 - $41.79 $566,975 - $655,977	15,697 Added 7.68%	219,990 $8.07 Million
Q1 2023 May 02, 2023	BUY	$39.39 - $51.28 $312,520 - $406,855	7,934 Added 4.04%	204,293 $8.34 Million
Q4 2022 Jan 13, 2023	SELL	$41.75 - $54.5 $121,951 - $159,194	-2,921 Reduced 1.47%	196,359 $10.1 Million
Q3 2022 Oct 11, 2022	SELL	$43.76 - $53.42 $109,793 - $134,030	-2,509 Reduced 1.24%	199,280 $8.72 Million
Q2 2022 Jul 13, 2022	BUY	$46.53 - $55.17 $17,727 - $21,019	381 Added 0.19%	201,789 $10.6 Million
Q1 2022 Apr 11, 2022	BUY	$45.75 - $56.69 $253,272 - $313,835	5,536 Added 2.83%	201,408 $10.4 Million
Q4 2021 Jan 14, 2022	SELL	$41.32 - $61.25 $45,575 - $67,558	-1,103 Reduced 0.56%	195,872 $11.6 Million
Q3 2021 Dec 14, 2021	SELL	$39.25 - $50.42 $398,426 - $511,813	-10,151 Reduced 4.9%	196,975 $8.47 Million
Q2 2021 Aug 04, 2021	BUY	$35.91 - $40.68 $14,292 - $16,190	398 Added 0.19%	207,126 $8.11 Million
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $196,217 - $221,294	-5,859 Reduced 2.76%	206,728 $7.49 Million
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $177,357 - $225,525	-5,299 Reduced 2.43%	212,587 $7.83 Million
Q3 2020 Nov 03, 2020	SELL	$31.75 - $37.25 $339,121 - $397,867	-10,681 Reduced 4.67%	217,886 $8 Million
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $151,563 - $183,869	-5,032 Reduced 2.15%	228,567 $7.47 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $499,568 - $713,774	-18,482 Reduced 7.33%	233,599 $7.63 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $257,763 - $292,528	-7,830 Reduced 3.01%	252,081 $9.88 Million
Q3 2019 Nov 13, 2019	SELL	$32.49 - $42.13 $332,080 - $430,610	-10,221 Reduced 3.78%	259,911 $9.34 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $170,958 - $191,946	-4,623 Reduced 1.68%	270,132 $11.7 Million
Q1 2019 May 08, 2019	SELL	$37.5 - $41.2 $259,125 - $284,692	-6,910 Reduced 2.45%	274,755 $11.7 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $468,102 - $533,688	-12,168 Reduced 4.14%	281,665 $12.3 Million
Q3 2018 Nov 01, 2018	SELL	$34.47 - $41.81 $231,466 - $280,754	-6,715 Reduced 2.23%	293,833 $0
Q2 2018 Aug 07, 2018	SELL	$32.98 - $35.16 $139,142 - $148,340	-4,219 Reduced 1.38%	300,548 $10.9 Million
Q1 2018 May 03, 2018	SELL	$31.91 - $37.02 $262,523 - $304,563	-8,227 Reduced 2.63%	304,767 $10.8 Million
Q4 2017 Jan 29, 2018	BUY	$33.26 - $35.29 $65,921 - $69,944	1,982 Added 0.64%	312,994 $11.3 Million
Q3 2017 Nov 06, 2017	SELL	$31.0 - $34.15 $169,291 - $186,493	-5,461 Reduced 1.73%	311,012 $11.1 Million
Q2 2017 Aug 07, 2017	BUY	N/A	316,473	316,473 $10.6 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$13.4 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.1 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$7.53 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.36 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.41 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategy Asset Managers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategy Asset Managers LLC with notifications on news.

Account